Inizio Biotech.

Personalized solutions curated to maximize asset value at every opportunity.

Creating value today to maximize tomorrow.

At Inizio Biotech, we understand that every day is an opportunity to build towards the true value of your assets. Providing best-in-class services across the clinical development and commercialization journey, our biotech solutions are highly personalized and coordinated through a single strategic point of contact. We support you by guiding, validating, and inspiring the decisions that matter most.

Explore Inizio Biotech

Maximize value creation.

With our connected suite of capabilities, we deliver best-in-class biotech services to clients. Our empowered experts bring deep expertise across therapeutic areas, helping to mitigate risks and maximize value at every stage.

At the right time in the journey.

We appreciate that sometimes you will need us more, and sometimes less, so we personalize our solutions to scale up or down, just as you need us. Always bringing you a value creation mindset to help maximize every opportunity.

Phase I

Guiding clinical-phase decisions to create asset value.

Phase II

Maximize the value of your asset at phase II clinical milestones.

Phase III

Guiding your late-stage trials and adding value to your asset.

Personalized and dedicated services coordinated by a single strategic point of contact.

We bring you personalized and dedicated services exactly when you need them because we understand that every day is a value creation opportunity. Our integrated biotech solutions are coordinated by a single strategic point of contact, who understands your business, bringing efficiencies and ensuring connectivity in the services provided.

Get to know our leadership team.

Navigate this carousel with the arrows.

Headshot of Dean McAlister

Dean McAlister

Executive Vice President, Inizio Biotech

Read bio

Dean McAlister

Executive Vice President, Inizio Biotech

As EVP for Global Biotech Enterprise Solutions, Dean spearheads business development for Inizio efforts across our business units and agencies focused on emerging biotech organizations. Prior to this role commencing 1/1/22, Dean worked 5 years at STEM Healthcare, growing US business development and then as North America President. Before joining the healthcare services sector, Dean had an entire career at AstraZeneca, progressing through 16 roles with increasing responsibility in Sales, Training, Market Research, Marketing, Market Access, and US Executive Leadership.

Previous Next
Headshot of Colin Stanley

Colin Stanley

CCO, Inizio

Read bio

Colin Stanley

CCO, Inizio

Colin is Inizio’s Chief Commercial Officer and is responsible for our Commercial Activities and Business Development, with a particular emphasis on the support of our Large Enterprise Accounts and the infrastructure that supports our Global Sales Team. Prior to his current role, he was President of Inizio Advisory from September 2019, where he oversaw Inizio’s Consulting and Research Businesses. Before Inizio, Colin spent 20 years at ICON, where he held several leadership positions, including President of ICON Functional Services. Colin is a seasoned leader in the pharma industry, bringing 30 years of experience across both clinical development and commercialization. He has a strong track record of driving business growth, both organically and through M&A, and improving margins through process optimization. 

Previous Next
Headshot of Greg Flynn

Greg Flynn

Senior Advisor to Inizio Engage and Chairman of Patient Access Services.

Read bio

Greg Flynn

Senior Advisor to Inizio Engage and Chairman of Patient Access Services.

Joining Ashfield in 2005 as a Regional Account Director in the UK, Greg Flynn has since worked with our teams across the UK, Japan and the US. He established and ran our joint venture in Japan before moving to the US in 2017 to lead Engage. Greg was previously the President of Engage from 2019 - 2025.

Previous Next
Headshot of Reid Connolly

Reid Connolly

Global President, Inizio Evoke
CEO, Evoke

Read bio

Reid Connolly

Global President, Inizio Evoke
CEO, Evoke

Reid Connolly leads Inizio Evoke, a global health marketing, communications, and transformation platform dedicated to making health more human™. Since founding Evoke in 2006, Reid has been instrumental in evolving the agency into one of the most progressive, client-centric, and people-first agencies in the industry, embracing its digital and data-driven roots to create a uniquely integrated platform. Reid has also been recognized by PRWeek as one of the industry’s top voices, with honors on both the Health Influencer 50 and Health Influencer 30 lists. Prior to founding Evoke, Reid held senior leadership roles at Digitas Health, imc2, and Saatchi & Saatchi Healthcare, where he honed his expertise in integrated healthcare marketing. He has partnered with leading pharmaceutical and biotech companies, including AstraZeneca, Amgen, Boehringer Ingelheim, Gilead, GlaxoSmithKline, Novartis, and Pfizer.

Previous Next
Headshot of Elaine Ferguson

Elaine Ferguson

Global President,
Inizio Medical

Read bio

Elaine Ferguson

Global President,
Inizio Medical

Joining Medistrava in 2015, Elaine helped double the size of the organization through organic growth and acquisition to create a fully integrated medical, health economics and market access platform. Now, she joins us as President of Inizio Medical. As a trained neuropsychologist, Elaine has enjoyed a career in research and clinical practice before joining the industry, combining her background in science and behavior to drive evidence-based strategies that apply to real-world healthcare challenges.

Previous Next

Your market-leading commercialization partner.

Leveraging our connected suite of capabilities, our experts will guide you through each pivotal moment in your asset’s lifecycle, creating tailored solutions that simplify the complex, unlock value, and enhance treatment outcomes.